| 1 |
Aliyu M, Zohora FT, Anka AU, Ali K, Maleknia S, Saffarioun M, Azizi G. Interleukin-6 cytokine: An overview of the immune regulation, immune dysregulation, and therapeutic approach. Int Immunopharmacol 2022;111:109130. [PMID: 35969896 DOI: 10.1016/j.intimp.2022.109130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 2 |
Furuya K, Itoh N. A Rare Case of Neuromyelitis Optica Spectrum Disorders With Unknown Fever and Subacute Cognitive Decline With Normal Images. Cureus 2022. [DOI: 10.7759/cureus.24950] [Reference Citation Analysis]
|
| 3 |
Vega R, González B, Ortiz K, Martínez V, Carmona D, Vicente I, Chapa J, Chinea Á, Berlit P. A Case of Neuromyelitis Optica: Puerto Rican Woman with an Increased Time Lag to Diagnosis and a High Response to Eculizumab Therapy. Case Reports in Neurological Medicine 2022;2022:1-5. [DOI: 10.1155/2022/4311382] [Reference Citation Analysis]
|
| 4 |
Nasehi MM, Ghofrani M, Tabrizi A, Abdollah Gorji F, Khosravi B. The preventive Effectiveness of Rituximab in Pediatric Autoimmune and Inflammatory CNS Diseases Relapse: an Iranian Experience. Iran J Child Neurol 2022;16:167-82. [PMID: 36204433 DOI: 10.22037/ijcn.v16i3.29322] [Reference Citation Analysis]
|
| 5 |
John M, Maria E, Das S, T H. Identification of Novel Serum Proteins Associated with Myelination and Cholesterol Transport in Neuromyelitis Optica Spectrum Disorders by Mass Spectrometry. Ind J Clin Biochem. [DOI: 10.1007/s12291-021-01004-w] [Reference Citation Analysis]
|
| 6 |
Fujikawa P, Shah FA, Braford M, Patel K, Madey J. Neuromyelitis Optica in a Healthy Female After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA-1273 Vaccine. Cureus 2021;13:e17961. [PMID: 34660149 DOI: 10.7759/cureus.17961] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 7 |
Exuzides A, Sheinson D, Sidiropoulos P, Magrini F, Gholizadeh S, Surinach A, Cook L, Meyer CS, Yeaman M. Burden and cost of comorbidities in patients with neuromyelitis optica spectrum disorder. J Neurol Sci 2021;427:117530. [PMID: 34111762 DOI: 10.1016/j.jns.2021.117530] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Kishk NA, Abdelfattah W, Shalaby NM, Shehata HS, Hassan A, Hegazy MI, Abokrysha NT, Abdellatif D, Shawky SM, Abdo SS, Taha N, Fouad AM, Elmazny A, Ragab AH. The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in Egypt. BMC Neurol 2021;21:53. [PMID: 33535985 DOI: 10.1186/s12883-021-02083-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Cui C, Ruan Y, Qiu W. Potential role of the gut microbiota in neuromyelitis optica spectrum disorder: Implication for intervention. J Clin Neurosci 2020;82:193-9. [PMID: 33257156 DOI: 10.1016/j.jocn.2020.11.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 10 |
Sadeghpour N, Mirmosayyeb O, Bjørklund G, Shaygannejad V. Is Fertility Affected in Women of Childbearing Age with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder? J Mol Neurosci 2020;70:1829-35. [PMID: 32740781 DOI: 10.1007/s12031-020-01576-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 11 |
Huang Y, Lee J, Fan W, Hsu C, Tsai N, Lu C, Chang W, Tsai M. A CD33 frameshift variant is associated with neuromyelitis optica spectrum disorders. Biomedical Journal 2020. [DOI: 10.1016/j.bj.2020.07.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 12 |
Gomes NA, Silva PC, Teixeira YT, Eufrazio P, Souza AD, Rojas H, Brant R, Gomes Neto A, Christo PP, Simões RT, Fernandes KS. HLA-G Ins/Del polymorphism and +3142C/G SNP are not related to neuromyelitis optica spectrum disorder (NMOSD) development, disability status or anti-aquaporin 4 presence in Brazilian patients. J Neuroimmunol 2020;339:577112. [PMID: 31765953 DOI: 10.1016/j.jneuroim.2019.577112] [Reference Citation Analysis]
|
| 13 |
Zarei S, Maldonado I, Franqui-Dominguez L, Rubi C, Rosa YT, Diaz-Marty C, Coronado G, Nieves MCR, Akhlaghipour G, Chinea A. Impact of delayed treatment on exacerbations of multiple sclerosis among Puerto Rican patients. Surg Neurol Int 2019;10:200. [PMID: 31768280 DOI: 10.25259/SNI_252_2019] [Reference Citation Analysis]
|
